The cost for each drug can easily exceed $1000 per month
GLP-1 medications like semaglutide and tirzepatide work by mimicking a naturally occurring hormone that helps regulate: These medications help patients feel fuller longer, reduce cravings, and support metabolic balancemaking weight loss more achievable without extreme dieting
It does not constitute medical advice and should not replace consultation with a qualified healthcare provider
Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
Retatrutide targets three receptors, offering broader metabolic effects compared to Tirzepatides two